Danaher Corporation Appoints Greg Milosevich as New Executive Vice President for Life Sciences

Danaher Corporation Appoints Greg Milosevich as Executive Vice President for Life Sciences



On June 27, 2025, Danaher Corporation, known for its innovation in life sciences and diagnostics, announced the appointment of Greg Milosevich to the role of Executive Vice President of Life Sciences. This new position for Milosevich will be effective from July 1, 2025, as per the announcement made by the company's Board of Directors.

A Steady Climb at Danaher


Milosevich’s ascent within Danaher has been noteworthy since he joined the company in 2010 through the acquisition of Molecular Devices. Over the years, he has taken on various roles that reflect both his capabilities and the trust the company places in him. Since 2021, he has been serving as the Vice President and Group Executive of the Life Sciences Innovations Group. In this crucial position, he oversaw revered brands including Beckman Coulter Life Sciences, Sciex, Leica Microsystems, Molecular Devices, Phenomenex, Abcam, IDBS, and Genedata.

His impressive background was highlighted by Rainer Blair, President and Chief Executive Officer of Danaher, who indicated that Milosevich has been pivotal to advancing the Life Sciences Innovations Group. Blair praised Milosevich for his consistent performance, strong customer focus, and an exceptional ability to form high-performing teams, reflecting the core values of the Danaher Business System.

The Vision Moving Forward


In his expanded role as Executive Vice President, Milosevich aims to continue driving Danaher’s vision in the Life Sciences sector, leveraging advanced science and technology to tackle pressing health challenges worldwide. His commitment resonates with Danaher’s mission of improving human health through innovative solutions.

Milosevich holds a bachelor’s degree in physics from the University of Puget Sound, graduating Summa Cum Laude. His academic and professional background equips him well for this significant leadership position within the company. As he embarks on this new chapter, he will report directly to Rainer Blair, indicating the critical nature of his role within the organization.

Danaher’s Commitment to Health Solutions


Danaher remains committed to elevating the quality of life for millions globally through its innovative life sciences and diagnostics solutions. With a dedicated workforce of approximately 63,000 individuals worldwide, the organization seeks to leverage its scientific expertise to foster faster and more effective healthcare solutions.

As they look to the future, Danaher focuses on scientific excellence, continuous improvement, and innovation — principles that are crucial for surviving and thriving in today's rapidly evolving healthcare landscape. The appointment of Greg Milosevich is seen as a strategic move to augment these initiatives, ensuring that Danaher continues to stand at the forefront of industry advancements.

As the world faces numerous health challenges, the role of leaders like Milosevich will be essential in steering organizations toward breakthroughs that can ultimately lead to effective therapies and improved healthcare outcomes. The future under his leadership in Life Sciences will undoubtedly be worth watching.

In summary, Milosevich's journey from Vice President to Executive Vice President at one of the leading corporations in life sciences symbolizes not only personal achievement but also the strategic direction that Danaher continues to pursue in enhancing global health through innovation and collaboration.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.